In September the California Department of Public Health announced that it would be allocating up to $1.5 million dollars annually to organizations that receive approval through their application process. The term of the grant is expected to be 32 months and is anticipated to be January 1, 2020 – August 31, 2022. We are happy to announce that RxSafe Marin has been approved by the CDPH to receive $255,000 over the next 32 months in order to maintain existing efforts and begin new programs. These funds will allow RxSafe to continue it’s work of preventing overprescribing, addressing and reducing stigma in the community, expanding the availability of MAT services, and promoting the dissemination of Naloxone all in service of preventing opioid-related overdose deaths.
- Opioid Overdose Epidemic is Rapidly Spreading Across the Bay Area
- Pharmacies Face 1st Trial Over Role in Opioid Crisis
- Rehab vs. Jail Time: The Choice is Clear
- Marin Voice: Let’s strengthen county response to accelerated overdose deaths
- Purdue Pharma Reaches $8B Opioid Deal With Justice Department Over OxyContin Sales